Following podcaster Joe Rogan’s claim that he quickly recovered from COVID-19 by using ivermectin, several national news outlets criticized Rogan, falsely accusing him of promoting a ‘dangerous horse dewormer.”
“Do I have to sue CNN? They’re making s*** up — they keep saying I’m taking horse dewormer. I literally got it from a doctor,” Rogan said during his podcast. “It’s an American company — they won the Nobel Prize in 2015 for use in human beings, and CNN is saying I’m taking horse dewormer. They must know that’s a lie.”
According to hundreds of studies on the efficacy of alternative treatments for COVID, Ivermectin is scientifically proven to show a high success rate in early improvement.
The Indian state of Uttar Pradesh recently claimed that it was the first state to have introduced a large-scale “therapeutic” use of Ivermectin, adding that the drug led to a dramatic reduction in the fatality rate as compared to other states.
Ivermectin is historically inexpensive. Oral tablets are usually around $3 per tablet, depending on the country and pharmacy you visit. Ivermectin’s average U.S. retail price is around $5 per generic tablet.
Recently, the Therapeutic Goods Administration (TGA) of Australia officially banned doctors from prescribing ivermectin for COVID-19.
The three reasons given for the TGA’s decision were revealing. “Firstly, there are a number of significant public health risks associated with taking ivermectin,” begins the statement.
The statement continues:
“…in an attempt to prevent COVID-19 infection rather than getting vaccinated. Individuals who believe that they are protected from infection by taking ivermectin may choose not to get tested or to seek medical care if they experience symptoms.”
A fairly recent massive expert medical review shows that unless you have a high parasite load, Ivermectin is effectively safer than Tylenol. The study found no accidental Ivermectin overdoses including in infants and young children that had a lethal outcome, out of billions of doses given.
One example in the review described someone who took a suicidal dose of Ivermectin, and after treatment still survived.
“A suicidal intake of ivermectin was reported in a 19-year-old woman with severe
Loa-Lao filariasis. She developed nausea and vomiting, and moderate neurological
manifestations including ataxia, reactive mydriasis, and hyperreflexia after possibly
ingesting 100 times the recommended therapeutic dose (≈400 3-mg ivermectin
tablets). She received conventional supportive treatment and could be discharged from
the hospital on day 4 post-ingestion [Djeunga et al., 2019].”
Additionally, the CDC currently recommends that the government require certain refugees to take Ivermectin in order to enter the US.
“Prior to departure for the United States, all refugees originating from the Middle East, Asia, North Africa, Latin American, & Caribbean should receive presumptive therapy with ivermectin for Strongyloides infection and with albendazole for infections caused by soil-transmitted helminths. Dosing for ivermectin may be based on weight and available tablet size.”
According to the first-quarter results published by Pfizer this week, its coronavirus jab has racked up billions for the biopharma giant in the first three months of 2021.
The financial results also revealed that Pfizer has vastly exceeded its Covid-19 vaccine sales forecast of $15bn, and now expects the jab to bring in over $30bn of revenue in 2021 – an increase of 73% on previously anticipated figures.
According to a recent report, Pfizer is planning on recommending their new twice-per-day COVID pill the company is developing alongside their proprietary vaccines.
“Success against COVID-19 will likely require both vaccines & treatments,” Pfizer CEO Albert Bourla said on Twitter recently. “We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate-specifically designed to combat SARS-CoV-2-in non-hospitalized, low-risk adults.”
Two COVID-19 antiviral pills are now in Phase 3 trials and are bringing claims by the national and international media that a proven oral treatment will soon be available to quell the SARS-CoV-2 infection.
Pfizer’s PF-07321332, in combination with the HIV antiviral ritonavir, has begun Phase 2/3 testing as a treatment for people who are infected with SARS-CoV-2 but who are less likely to be hospitalized with COVID-19.
Merck & Co. with partner Ridgeback Biotherapeutics is well into a Phase 3 trial of molnupiravir as a treatment for people who are in early infection. The firms announced this week that they are enrolling uninfected people who live with someone who is COVID-19 positive in a new Phase 3 trial to test the small molecule’s ability to prevent SARS-CoV-2 infection.
Pfizer has been extremely aggressive in trying to protect the details of its international COVID19 vaccine agreements. However, one of their contracts has allegedly leaked.
Hundreds of doctors in the US and throughout the world are prescribing ivermectin to treat their COVID patients, however, it appears that some hospitals in the US are beginning to follow Australia’s lead.
In a recently published undercover video, doctors working for the US department of health and human services can be heard talking about how hospitals have begun to ban prescribing Ivermectin to patients.
CLIP OF UNDERCOVER VIDEO: